Good day to everyone and a warm welcome to our all of our new members,
Actinium Pharmaceuticals, Inc. (NYSE-MKT: ATNM) Analyst Report is Below.
For you newer members, we hope you are feeling the difference here with us as we do our very best to ensure that you receive only quality with us.
So far 2015 has been an amazing year. As most of you that have been with us for while have seen, our growth over the last two years has been exponential. Along with a large following from both the analyst reports we issue on behalf of our CFA’s and our newsletter’s comes a lot of responsibility. We are aware of this and always look forward to being good stewards of your trust and loyalty. Make no mistake there are a lot of good people here doing our very best to get you the highest quality and timely information. We have received a lot of compliments and admiration from our competitors and members on how we manage our company as well. We are definitely paving the way.
Our Core Values
Small Cap IR picks are always stand-and-deliver companies
Small Cap IR picks companies listed on NYSE or NASDAQ exchanges, no pinks at all and rarely a full reporting OTCQB.
Small Cap IR works the “Street” like a pro
Small Cap IR never naps on the job
Want to receive our alerts on time?
Text “SmallCapIR” to 25827 with keyword
Actinium Pharmaceuticals, Inc. (NYSE-MKT: ATNM) Analyst Report
The following brief report is provided only to inform the investing public.
Use the following PDF link to view full report.
Published June 2, 2015
By agreeing to this disclaimer it indicates you have read and understand the full disclaimer. You will receive the full research report and additional profiles, alerts and updates from Small Cap Specialists, LLC newsletters including Small Cap IR. All information provided on any websites owned or managed by Small Cap Specialists, LLC and/or our newsletter and/or any distributed publication and/or media delivered through and/or by Small Cap Specialists, LLC pertaining to investing, stocks, securities must be understood as information provided and not investment advice. None of the information provided in this website constitutes a recommendation that any investment is suitable for any person. We advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in any stock including those featured on any of Small Cap Specialists, LLC ’s (herein referred to as the “Group”) websites, publications, applications, software, or other branded media including but not limited to the websites owned or managed by Small Cap Specialists, LLC (herein referred to as “SCS Websites”).
No Tolerance SPAM Policy: We will not sell or re-distribute your Email to any 3rd party. If applicable, please unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails.
Small Cap Specialists, LLC HAS NEVER and WILL NEVER accept free trading shares on behalf of ANY companies listed on SCS Websites or in our email newsletter, or other Social Media.
We encourage all to read the SEC’s INVESTOR ALERT before reading our Newsletter.
All information provided regarding the companies featured on SCS Websites is provided in public forums directly from the companies themselves and contained within the Issuers’ SEC filings, OTC Disclosure & News Service filings, news releases, company websites as well as other sources of publicly available information. The profiles of Issuers’ does not represent a solicitation or recommendation to buy, sell, or hold these or any other securities. The receiver of SCS Websites shall not create, under any circumstances, any implication that there has been no change in the affairs of the issuers’ profiled since the date of the review. The advertisements within SCS Websites are not to be construed as offers to purchase securities in the companies which may be the subject of such advertisements pursuant to federal or state law or the laws of any foreign jurisdiction.
Past performance may not be indicative of future results. Therefore, you should not assume that the future performance of any specific investment or investment strategy will be profitable or equal to corresponding past performance levels. Each investment decision you make should be determined with reference to the specific information available for such investment, and not based upon the success of past recommendations.
This website and information within the website contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in an any featured equities’ regulatory filings and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. Any forward-looking statements found on SCS Websites are made as of the date thereof and the Group undertakes no obligation to update such statements.
An investment in an OTC security is speculative and involves a high degree of risk. Many OTC securities are relatively illiquid, or “thinly traded,” which tends to increase price volatility. Illiquid securities are often difficult for investors to buy or sell without dramatically affecting the quoted price. In some cases, the liquidation of a position in an OTC security may not be possible within a reasonable period of time.
The Group (and our Media Publications/Products) is periodically compensated for describing certain securities of the issuers highlighted on SCS Websites. SCS Websites has been compensated sixty thousand dollars for media services in relation to ATNM by Edge Media, LLC for a period of three days, starting on June 2, 2015. In addition, in some instances the Group and SCS Websites’s affiliates, officers, directors and employees may also have bought or may buy, or have sold or may sell the securities discussed in SCS Websites and may profit in the event of a rise in value of those securities. Each investor must make investment decisions based on his or her circumstances and judgment of market conditions under the counsel of a licensed Financial Advisor, Broker, or Dealer.
The Group does not review, and is not responsible for confirming, the accuracy of documents pertaining to issuers that are publicly traded and information submitted to the Group for inclusion in SCS Websites. The issuers and their management are solely responsible for the accuracy of any information regarding their security that has been provided to the Group for dissemination in SCS Websites. INVESTORS ARE URGED TO CONFIRM THE ACCURACY OF ANY INFORMATION OBTAINED FROM SCS WEBSITES PRIOR TO MAKING ANY INVESTMENT DECISION.
The Group volunteers disclosure of company compensation pertaining to public companies’ securities. We DO NOT engage in private transactions which may involve; Restricted Securities, Convertible Liabilities, Options Contracts, Warrants, Subscriptions, Exception Specific Securities, Corporate Bonds, and other financial instruments.
Small Cap Specialists, LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission, FINRA, and is not a Broker/Dealer. The group does not engage in high frequency trading.